ATE246503T1 - Verwendung eines nikotin-rezeptor agonisten zur herstellung eines medikaments zur behandlung von zwangsneurosen - Google Patents
Verwendung eines nikotin-rezeptor agonisten zur herstellung eines medikaments zur behandlung von zwangsneurosenInfo
- Publication number
- ATE246503T1 ATE246503T1 AT99957446T AT99957446T ATE246503T1 AT E246503 T1 ATE246503 T1 AT E246503T1 AT 99957446 T AT99957446 T AT 99957446T AT 99957446 T AT99957446 T AT 99957446T AT E246503 T1 ATE246503 T1 AT E246503T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor agonist
- nicotine receptor
- neurosis
- medication
- producing
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 3
- 229960002715 nicotine Drugs 0.000 title abstract 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000018 receptor agonist Substances 0.000 title abstract 3
- 229940044601 receptor agonist Drugs 0.000 title abstract 3
- 206010029333 Neurosis Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000015238 neurotic disease Diseases 0.000 title 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803732A SE9803732D0 (sv) | 1998-11-02 | 1998-11-02 | Nicotine treatment for obsessive compulsive disorder |
| PCT/SE1999/001948 WO2000025783A1 (en) | 1998-11-02 | 1999-10-29 | Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246503T1 true ATE246503T1 (de) | 2003-08-15 |
Family
ID=20413142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957446T ATE246503T1 (de) | 1998-11-02 | 1999-10-29 | Verwendung eines nikotin-rezeptor agonisten zur herstellung eines medikaments zur behandlung von zwangsneurosen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1126846B1 (de) |
| JP (1) | JP2002528501A (de) |
| AT (1) | ATE246503T1 (de) |
| AU (1) | AU1514700A (de) |
| CA (1) | CA2347855A1 (de) |
| DE (1) | DE69910242T2 (de) |
| DK (1) | DK1126846T3 (de) |
| ES (1) | ES2203210T3 (de) |
| NZ (1) | NZ511226A (de) |
| PT (1) | PT1126846E (de) |
| SE (1) | SE9803732D0 (de) |
| WO (1) | WO2000025783A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| CN100398103C (zh) | 2000-10-13 | 2008-07-02 | 神经研究公司 | 通过烟碱性受体激动剂和单胺能物质的联合作用治疗情感性精神障碍 |
| DE20018196U1 (de) | 2000-10-25 | 2001-01-11 | Peter, Michael N., 22297 Hamburg | Erzeugnis aus Zuckerware für Raucherentwöhnung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776956A (en) * | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
-
1998
- 1998-11-02 SE SE9803732A patent/SE9803732D0/xx unknown
-
1999
- 1999-10-29 WO PCT/SE1999/001948 patent/WO2000025783A1/en not_active Ceased
- 1999-10-29 DK DK99957446T patent/DK1126846T3/da active
- 1999-10-29 AU AU15147/00A patent/AU1514700A/en not_active Abandoned
- 1999-10-29 NZ NZ511226A patent/NZ511226A/xx unknown
- 1999-10-29 PT PT99957446T patent/PT1126846E/pt unknown
- 1999-10-29 AT AT99957446T patent/ATE246503T1/de not_active IP Right Cessation
- 1999-10-29 EP EP99957446A patent/EP1126846B1/de not_active Expired - Lifetime
- 1999-10-29 JP JP2000579224A patent/JP2002528501A/ja not_active Withdrawn
- 1999-10-29 DE DE69910242T patent/DE69910242T2/de not_active Expired - Fee Related
- 1999-10-29 CA CA002347855A patent/CA2347855A1/en not_active Abandoned
- 1999-10-29 ES ES99957446T patent/ES2203210T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2203210T3 (es) | 2004-04-01 |
| SE9803732D0 (sv) | 1998-11-02 |
| DE69910242T2 (de) | 2004-06-17 |
| EP1126846A1 (de) | 2001-08-29 |
| EP1126846B1 (de) | 2003-08-06 |
| AU1514700A (en) | 2000-05-22 |
| DK1126846T3 (da) | 2003-09-29 |
| JP2002528501A (ja) | 2002-09-03 |
| WO2000025783A1 (en) | 2000-05-11 |
| CA2347855A1 (en) | 2000-05-11 |
| NZ511226A (en) | 2003-01-31 |
| DE69910242D1 (de) | 2003-09-11 |
| PT1126846E (pt) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001001973A3 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| AU2005202257C1 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
| PT840601E (pt) | Thip para o tratamento de desordens do sono | |
| DE60222137D1 (de) | Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen | |
| DE602006021444D1 (de) | Therapie zur behandlung der überaktiven blase | |
| ATE451368T1 (de) | Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems | |
| DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| NO20005059L (no) | Nye behandlinger for nervøse lidelser | |
| ATE246503T1 (de) | Verwendung eines nikotin-rezeptor agonisten zur herstellung eines medikaments zur behandlung von zwangsneurosen | |
| BRPI0412924A (pt) | tratamento pré-operatório de dor pós-operatória | |
| NO20005131L (no) | Nye behandlinger for nervøse forstyrrelser | |
| TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
| JP2003524573A5 (de) | ||
| SE9904424D0 (sv) | Use of interleukin-6 in combination with leptin in treatment of obesity | |
| DE69923698D1 (de) | Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung | |
| ATE374021T1 (de) | Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post- chirurgischen schmerzbehandlung | |
| DE60020550D1 (de) | Methode und mittel zur behandlung eines post-poliosyndroms | |
| ATE345124T1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia | |
| Al-Doghether | An overview of pharmacological aids available to enhance smoking cessation. | |
| TR200100670T2 (tr) | R(+)-alfa-(2,3-Dimetoksifenil)-1- [2-(4-florofenil)etil]-4-piperidinmetanol' ün uyku düzensizlikleri tedavisinde kullanımı. | |
| CA2532330A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| HK1042238A1 (en) | Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group | |
| HK1042238B (en) | Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1126846 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |